Impact of Advertising on Prescription Drugs
WASHINGTON - According to a study by the National Institute for Health Care Management (NIHCM) Research and Educational Foundation, prescription drugs that are heavily advertised to consumers are responsible for a significant portion of the recent rise in pharmaceutical spending in the US. 25 top selling medicines promoted to consumers in 1999 accounted for 40.7% -- or $7.2 billion -- increase in retail drug spending.
The anti-allergy drug Claritin topped the list of drugs promoted most widely to consumers for the second year in a row. Schering-Plough spent $137 million advertising various forms of Claritin to consumers in 1999. The study found that sales of Claitin were up 21% from 1998 to 1999. Other leading drugs were Zytec (Pfizer), Allegra (Aventis), and Celebrex had the most successful prescription drug launch in history, reaching sales of almost $1.3 billion in its first year.
A spokesperson for NIHCM says these numbers should raise many questions. Among the most important is whether pharmaceutical companies are more focused on becoming marketing powerhouses or developing truly innovative new drugs. Proponents argue that the ads have added to the information consumers are receiving about health conditions and diseases. For more information visit www.nihcm.org,
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
